Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
Condition: Hemodialysis Intervention: Drug: Sacubitril-valsartan Sponsors: Brigham and Women's Hospital; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2022 Category: Research Source Type: clinical trials
Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction
Condition: Heart Failure Interventions: Drug: Sacubitril-valsartan; Drug: Enalapril; Drug: placebo; Drug: Placebo Sponsors: Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań; Medical Research Agency, Poland; Medical University of Bialystok; University of Opole; Medical University of Gdańsk; Medical University of Silesia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2022 Category: Research Source Type: clinical trials
